img

Global CAR T-Cell-Based Drug Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global CAR T-Cell-Based Drug Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application

Chimeric antigen receptor (CAR) T-cell therapy is a way to get immune cells called T cells (a type of white blood cell) to fight cancer by changing them in the lab so they can find and destroy cancer cells. CAR T-cell therapy is also sometimes talked about as a type of cell-based gene therapy, because it involves altering the genes inside T cells to help them attack the cancer.
CAR T-Cell-Based Drug report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global CAR T-Cell-Based Drug market is projected to reach US$ 19190 million in 2029, increasing from US$ 2806 million in 2022, with the CAGR of 29.4% during the period of 2024 to 2029. Demand from Lymphoma and Multiple Myeloma are the major drivers for the industry.
The CAR T-cell-based drug market is driven by the growing demand for innovative and targeted cancer therapies. Chimeric Antigen Receptor (CAR) T-cell therapy is a revolutionary approach that involves genetically modifying a patient's T cells to recognize and attack cancer cells. The success of CAR T-cell therapies in treating certain types of blood cancers, such as leukemia and lymphoma, has fueled market growth and encouraged research into expanding the application of CAR T-cell therapy to other solid tumor malignancies. However, the market also faces challenges, including the high cost of CAR T-cell therapy and the complexity of the manufacturing process, which may limit patient access. Additionally, the potential for severe side effects and the need for patient selection and management pose regulatory and clinical challenges. To succeed, companies must focus on advancing research, streamlining the production process, collaborating with healthcare providers to improve patient access and support, and addressing safety and efficacy concerns to establish CAR T-cell-based drugs as a transformative treatment option for cancer patients.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global CAR T-Cell-Based Drug market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report



By Company


Novartis
Gilead Sciences
Bristol-Myers Squibb
J & J
JW Therapeutics
FOSUNKite
CARsgen Therapeutics
Autolus Therapeutics
Sorrento Therapeutics
Mustang Bio
Bluebird Bio
Cellectis
Allogene Therapeutics
Celyad
Segment by Type
CD19-targeted
BCMA-targeted

Segment by Application


Lymphoma
Multiple Myeloma
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries

Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia

Latin America
Mexico
Brazil

Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the CAR T-Cell-Based Drug market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2018-2024, 2024-2029).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, CAR T-Cell-Based Drug introduction, etc. CAR T-Cell-Based Drug Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12Mr Accuracy reports’s Conclusions of CAR T-Cell-Based Drug market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by Mr Accuracy reports.

Table of Content

1 Market Overview of CAR T-Cell-Based Drug
1.1 CAR T-Cell-Based Drug Market Overview
1.1.1 CAR T-Cell-Based Drug Product Scope
1.1.2 CAR T-Cell-Based Drug Market Status and Outlook
1.2 Global CAR T-Cell-Based Drug Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global CAR T-Cell-Based Drug Market Size by Region (2018-2029)
1.4 Global CAR T-Cell-Based Drug Historic Market Size by Region (2018-2024)
1.5 Global CAR T-Cell-Based Drug Market Size Forecast by Region (2024-2029)
1.6 Key Regions, CAR T-Cell-Based Drug Market Size (2018-2029)
1.6.1 North America CAR T-Cell-Based Drug Market Size (2018-2029)
1.6.2 Europe CAR T-Cell-Based Drug Market Size (2018-2029)
1.6.3 Asia-Pacific CAR T-Cell-Based Drug Market Size (2018-2029)
1.6.4 Latin America CAR T-Cell-Based Drug Market Size (2018-2029)
1.6.5 Middle East & Africa CAR T-Cell-Based Drug Market Size (2018-2029)
2 CAR T-Cell-Based Drug Market by Type
2.1 Introduction
2.1.1 CD19-targeted
2.1.2 BCMA-targeted
2.2 Global CAR T-Cell-Based Drug Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global CAR T-Cell-Based Drug Historic Market Size by Type (2018-2024)
2.2.2 Global CAR T-Cell-Based Drug Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America CAR T-Cell-Based Drug Revenue Breakdown by Type (2018-2029)
2.3.2 Europe CAR T-Cell-Based Drug Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific CAR T-Cell-Based Drug Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America CAR T-Cell-Based Drug Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa CAR T-Cell-Based Drug Revenue Breakdown by Type (2018-2029)
3 CAR T-Cell-Based Drug Market Overview by Application
3.1 Introduction
3.1.1 Lymphoma
3.1.2 Multiple Myeloma
3.2 Global CAR T-Cell-Based Drug Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global CAR T-Cell-Based Drug Historic Market Size by Application (2018-2024)
3.2.2 Global CAR T-Cell-Based Drug Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America CAR T-Cell-Based Drug Revenue Breakdown by Application (2018-2029)
3.3.2 Europe CAR T-Cell-Based Drug Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific CAR T-Cell-Based Drug Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America CAR T-Cell-Based Drug Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa CAR T-Cell-Based Drug Revenue Breakdown by Application (2018-2029)
4 CAR T-Cell-Based Drug Competition Analysis by Players
4.1 Global CAR T-Cell-Based Drug Market Size by Players (2018-2024)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in CAR T-Cell-Based Drug as of 2022)
4.3 Date of Key Players Enter into CAR T-Cell-Based Drug Market
4.4 Global Top Players CAR T-Cell-Based Drug Headquarters and Area Served
4.5 Key Players CAR T-Cell-Based Drug Product Solution and Service
4.6 Competitive Status
4.6.1 CAR T-Cell-Based Drug Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Novartis
5.1.1 Novartis Profile
5.1.2 Novartis Main Business
5.1.3 Novartis CAR T-Cell-Based Drug Products, Services and Solutions
5.1.4 Novartis CAR T-Cell-Based Drug Revenue (US$ Million) & (2018-2024)
5.1.5 Novartis Recent Developments
5.2 Gilead Sciences
5.2.1 Gilead Sciences Profile
5.2.2 Gilead Sciences Main Business
5.2.3 Gilead Sciences CAR T-Cell-Based Drug Products, Services and Solutions
5.2.4 Gilead Sciences CAR T-Cell-Based Drug Revenue (US$ Million) & (2018-2024)
5.2.5 Gilead Sciences Recent Developments
5.3 Bristol-Myers Squibb
5.3.1 Bristol-Myers Squibb Profile
5.3.2 Bristol-Myers Squibb Main Business
5.3.3 Bristol-Myers Squibb CAR T-Cell-Based Drug Products, Services and Solutions
5.3.4 Bristol-Myers Squibb CAR T-Cell-Based Drug Revenue (US$ Million) & (2018-2024)
5.3.5 J & J Recent Developments
5.4 J & J
5.4.1 J & J Profile
5.4.2 J & J Main Business
5.4.3 J & J CAR T-Cell-Based Drug Products, Services and Solutions
5.4.4 J & J CAR T-Cell-Based Drug Revenue (US$ Million) & (2018-2024)
5.4.5 J & J Recent Developments
5.5 JW Therapeutics
5.5.1 JW Therapeutics Profile
5.5.2 JW Therapeutics Main Business
5.5.3 JW Therapeutics CAR T-Cell-Based Drug Products, Services and Solutions
5.5.4 JW Therapeutics CAR T-Cell-Based Drug Revenue (US$ Million) & (2018-2024)
5.5.5 JW Therapeutics Recent Developments
5.6 FOSUNKite
5.6.1 FOSUNKite Profile
5.6.2 FOSUNKite Main Business
5.6.3 FOSUNKite CAR T-Cell-Based Drug Products, Services and Solutions
5.6.4 FOSUNKite CAR T-Cell-Based Drug Revenue (US$ Million) & (2018-2024)
5.6.5 FOSUNKite Recent Developments
5.7 CARsgen Therapeutics
5.7.1 CARsgen Therapeutics Profile
5.7.2 CARsgen Therapeutics Main Business
5.7.3 CARsgen Therapeutics CAR T-Cell-Based Drug Products, Services and Solutions
5.7.4 CARsgen Therapeutics CAR T-Cell-Based Drug Revenue (US$ Million) & (2018-2024)
5.7.5 CARsgen Therapeutics Recent Developments
5.8 Autolus Therapeutics
5.8.1 Autolus Therapeutics Profile
5.8.2 Autolus Therapeutics Main Business
5.8.3 Autolus Therapeutics CAR T-Cell-Based Drug Products, Services and Solutions
5.8.4 Autolus Therapeutics CAR T-Cell-Based Drug Revenue (US$ Million) & (2018-2024)
5.8.5 Autolus Therapeutics Recent Developments
5.9 Sorrento Therapeutics
5.9.1 Sorrento Therapeutics Profile
5.9.2 Sorrento Therapeutics Main Business
5.9.3 Sorrento Therapeutics CAR T-Cell-Based Drug Products, Services and Solutions
5.9.4 Sorrento Therapeutics CAR T-Cell-Based Drug Revenue (US$ Million) & (2018-2024)
5.9.5 Sorrento Therapeutics Recent Developments
5.10 Mustang Bio
5.10.1 Mustang Bio Profile
5.10.2 Mustang Bio Main Business
5.10.3 Mustang Bio CAR T-Cell-Based Drug Products, Services and Solutions
5.10.4 Mustang Bio CAR T-Cell-Based Drug Revenue (US$ Million) & (2018-2024)
5.10.5 Mustang Bio Recent Developments
5.11 Bluebird Bio
5.11.1 Bluebird Bio Profile
5.11.2 Bluebird Bio Main Business
5.11.3 Bluebird Bio CAR T-Cell-Based Drug Products, Services and Solutions
5.11.4 Bluebird Bio CAR T-Cell-Based Drug Revenue (US$ Million) & (2018-2024)
5.11.5 Bluebird Bio Recent Developments
5.12 Cellectis
5.12.1 Cellectis Profile
5.12.2 Cellectis Main Business
5.12.3 Cellectis CAR T-Cell-Based Drug Products, Services and Solutions
5.12.4 Cellectis CAR T-Cell-Based Drug Revenue (US$ Million) & (2018-2024)
5.12.5 Cellectis Recent Developments
5.13 Allogene Therapeutics
5.13.1 Allogene Therapeutics Profile
5.13.2 Allogene Therapeutics Main Business
5.13.3 Allogene Therapeutics CAR T-Cell-Based Drug Products, Services and Solutions
5.13.4 Allogene Therapeutics CAR T-Cell-Based Drug Revenue (US$ Million) & (2018-2024)
5.13.5 Allogene Therapeutics Recent Developments
5.14 Celyad
5.14.1 Celyad Profile
5.14.2 Celyad Main Business
5.14.3 Celyad CAR T-Cell-Based Drug Products, Services and Solutions
5.14.4 Celyad CAR T-Cell-Based Drug Revenue (US$ Million) & (2018-2024)
5.14.5 Celyad Recent Developments
6 North America
6.1 North America CAR T-Cell-Based Drug Market Size by Country (2018-2029)
6.2 United States
6.3 Canada
7 Europe
7.1 Europe CAR T-Cell-Based Drug Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific CAR T-Cell-Based Drug Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America CAR T-Cell-Based Drug Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa CAR T-Cell-Based Drug Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 CAR T-Cell-Based Drug Market Dynamics
11.1 CAR T-Cell-Based Drug Industry Trends
11.2 CAR T-Cell-Based Drug Market Drivers
11.3 CAR T-Cell-Based Drug Market Challenges
11.4 CAR T-Cell-Based Drug Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List

List of Figure

List of Tables
Table 1. Global Market CAR T-Cell-Based Drug Market Size (US$ Million) Comparison by Region 2018 VS 2022 VS 2029
Table 2. Global CAR T-Cell-Based Drug Market Size by Region (2018-2024) & (US$ Million)
Table 3. Global CAR T-Cell-Based Drug Market Size Share by Region (2018-2024)
Table 4. Global CAR T-Cell-Based Drug Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 5. Global CAR T-Cell-Based Drug Forecasted Market Size Share by Region (2024-2029)
Table 6. Global CAR T-Cell-Based Drug Market Size (US$ Million) by Type: 2018 VS 2022 VS 2029
Table 7. Global CAR T-Cell-Based Drug Market Size by Type (2018-2024) & (US$ Million)
Table 8. Global CAR T-Cell-Based Drug Revenue Market Share by Type (2018-2024)
Table 9. Global CAR T-Cell-Based Drug Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 10. Global CAR T-Cell-Based Drug Revenue Market Share by Type (2024-2029)
Table 11. North America CAR T-Cell-Based Drug Revenue by Type (2018-2024) & (US$ Million)
Table 12. North America CAR T-Cell-Based Drug Revenue by Type (2024-2029) & (US$ Million)
Table 13. Europe CAR T-Cell-Based Drug Revenue by Type (2018-2024) & (US$ Million)
Table 14. Europe CAR T-Cell-Based Drug Revenue by Type (2024-2029) & (US$ Million)
Table 15. Asia-Pacific CAR T-Cell-Based Drug Revenue by Type (2018-2024) & (US$ Million)
Table 16. Asia-Pacific CAR T-Cell-Based Drug Revenue by Type (2024-2029) & (US$ Million)
Table 17. Latin America CAR T-Cell-Based Drug Revenue by Type (2018-2024) & (US$ Million)
Table 18. Latin America CAR T-Cell-Based Drug Revenue by Type (2024-2029) & (US$ Million)
Table 19. Middle East and Africa CAR T-Cell-Based Drug Revenue by Type (2018-2024) & (US$ Million)
Table 20. Middle East and Africa CAR T-Cell-Based Drug Revenue by Type (2024-2029) & (US$ Million)
Table 21. Global CAR T-Cell-Based Drug Market Size (US$ Million) by Application: 2018 VS 2022 VS 2029
Table 22. Global CAR T-Cell-Based Drug Market Size by Application (2018-2024) & (US$ Million)
Table 23. Global CAR T-Cell-Based Drug Revenue Market Share by Application (2018-2024)
Table 24. Global CAR T-Cell-Based Drug Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 25. Global CAR T-Cell-Based Drug Revenue Market Share by Application (2024-2029)
Table 26. North America CAR T-Cell-Based Drug Revenue by Application (2018-2024) & (US$ Million)
Table 27. North America CAR T-Cell-Based Drug Revenue by Application (2024-2029) & (US$ Million)
Table 28. Europe CAR T-Cell-Based Drug Revenue by Application (2018-2024) & (US$ Million)
Table 29. Europe CAR T-Cell-Based Drug Revenue by Application (2024-2029) & (US$ Million)
Table 30. Asia-Pacific CAR T-Cell-Based Drug Revenue by Application (2018-2024) & (US$ Million)
Table 31. Asia-Pacific CAR T-Cell-Based Drug Revenue by Application (2024-2029) & (US$ Million)
Table 32. Latin America CAR T-Cell-Based Drug Revenue by Application (2018-2024) & (US$ Million)
Table 33. Latin America CAR T-Cell-Based Drug Revenue by Application (2024-2029) & (US$ Million)
Table 34. Middle East and Africa CAR T-Cell-Based Drug Revenue by Application (2018-2024) & (US$ Million)
Table 35. Middle East and Africa CAR T-Cell-Based Drug Revenue by Application (2024-2029) & (US$ Million)
Table 36. Global CAR T-Cell-Based Drug Revenue (US$ Million) by Players (2018-2024)
Table 37. Global CAR T-Cell-Based Drug Revenue Market Share by Players (2018-2024)
Table 38. Global Top Players Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in CAR T-Cell-Based Drug as of 2022)
Table 39. Date of Key Players Enter into CAR T-Cell-Based Drug Market
Table 40. Global CAR T-Cell-Based Drug Key Players Headquarters and Area Served
Table 41. CAR T-Cell-Based Drug Product Solution and Service
Table 42. Global CAR T-Cell-Based Drug Players Market Concentration Ratio (CR5 and HHI)
Table 43. Mergers & Acquisitions, Expansion Plans
Table 44. Novartis Basic Information List
Table 45. Novartis Description and Business Overview
Table 46. Novartis CAR T-Cell-Based Drug Products, Services and Solutions
Table 47. Revenue (US$ Million) in CAR T-Cell-Based Drug Business of Novartis (2018-2024)
Table 48. Novartis Recent Developments
Table 49. Gilead Sciences Basic Information List
Table 50. Gilead Sciences Description and Business Overview
Table 51. Gilead Sciences CAR T-Cell-Based Drug Products, Services and Solutions
Table 52. Revenue (US$ Million) in CAR T-Cell-Based Drug Business of Gilead Sciences (2018-2024)
Table 53. Gilead Sciences Recent Developments
Table 54. Bristol-Myers Squibb Basic Information List
Table 55. Bristol-Myers Squibb Description and Business Overview
Table 56. Bristol-Myers Squibb CAR T-Cell-Based Drug Products, Services and Solutions
Table 57. Revenue (US$ Million) in CAR T-Cell-Based Drug Business of Bristol-Myers Squibb (2018-2024)
Table 58. Bristol-Myers Squibb Recent Developments
Table 59. J & J Basic Information List
Table 60. J & J Description and Business Overview
Table 61. J & J CAR T-Cell-Based Drug Products, Services and Solutions
Table 62. Revenue (US$ Million) in CAR T-Cell-Based Drug Business of J & J (2018-2024)
Table 63. J & J Recent Developments
Table 64. JW Therapeutics Basic Information List
Table 65. JW Therapeutics Description and Business Overview
Table 66. JW Therapeutics CAR T-Cell-Based Drug Products, Services and Solutions
Table 67. Revenue (US$ Million) in CAR T-Cell-Based Drug Business of JW Therapeutics (2018-2024)
Table 68. JW Therapeutics Recent Developments
Table 69. FOSUNKite Basic Information List
Table 70. FOSUNKite Description and Business Overview
Table 71. FOSUNKite CAR T-Cell-Based Drug Products, Services and Solutions
Table 72. Revenue (US$ Million) in CAR T-Cell-Based Drug Business of FOSUNKite (2018-2024)
Table 73. FOSUNKite Recent Developments
Table 74. CARsgen Therapeutics Basic Information List
Table 75. CARsgen Therapeutics Description and Business Overview
Table 76. CARsgen Therapeutics CAR T-Cell-Based Drug Products, Services and Solutions
Table 77. Revenue (US$ Million) in CAR T-Cell-Based Drug Business of CARsgen Therapeutics (2018-2024)
Table 78. CARsgen Therapeutics Recent Developments
Table 79. Autolus Therapeutics Basic Information List
Table 80. Autolus Therapeutics Description and Business Overview
Table 81. Autolus Therapeutics CAR T-Cell-Based Drug Products, Services and Solutions
Table 82. Revenue (US$ Million) in CAR T-Cell-Based Drug Business of Autolus Therapeutics (2018-2024)
Table 83. Autolus Therapeutics Recent Developments
Table 84. Sorrento Therapeutics Basic Information List
Table 85. Sorrento Therapeutics Description and Business Overview
Table 86. Sorrento Therapeutics CAR T-Cell-Based Drug Products, Services and Solutions
Table 87. Revenue (US$ Million) in CAR T-Cell-Based Drug Business of Sorrento Therapeutics (2018-2024)
Table 88. Sorrento Therapeutics Recent Developments
Table 89. Mustang Bio Basic Information List
Table 90. Mustang Bio Description and Business Overview
Table 91. Mustang Bio CAR T-Cell-Based Drug Products, Services and Solutions
Table 92. Revenue (US$ Million) in CAR T-Cell-Based Drug Business of Mustang Bio (2018-2024)
Table 93. Mustang Bio Recent Developments
Table 94. Bluebird Bio Basic Information List
Table 95. Bluebird Bio Description and Business Overview
Table 96. Bluebird Bio CAR T-Cell-Based Drug Products, Services and Solutions
Table 97. Revenue (US$ Million) in CAR T-Cell-Based Drug Business of Bluebird Bio (2018-2024)
Table 98. Bluebird Bio Recent Developments
Table 99. Cellectis Basic Information List
Table 100. Cellectis Description and Business Overview
Table 101. Cellectis CAR T-Cell-Based Drug Products, Services and Solutions
Table 102. Revenue (US$ Million) in CAR T-Cell-Based Drug Business of Cellectis (2018-2024)
Table 103. Cellectis Recent Developments
Table 104. Allogene Therapeutics Basic Information List
Table 105. Allogene Therapeutics Description and Business Overview
Table 106. Allogene Therapeutics CAR T-Cell-Based Drug Products, Services and Solutions
Table 107. Revenue (US$ Million) in CAR T-Cell-Based Drug Business of Allogene Therapeutics (2018-2024)
Table 108. Allogene Therapeutics Recent Developments
Table 109. Celyad Basic Information List
Table 110. Celyad Description and Business Overview
Table 111. Celyad CAR T-Cell-Based Drug Products, Services and Solutions
Table 112. Revenue (US$ Million) in CAR T-Cell-Based Drug Business of Celyad (2018-2024)
Table 113. Celyad Recent Developments
Table 114. North America CAR T-Cell-Based Drug Market Size by Country (2018-2024) & (US$ Million)
Table 115. North America CAR T-Cell-Based Drug Market Size by Country (2024-2029) & (US$ Million)
Table 116. Europe CAR T-Cell-Based Drug Market Size by Country (2018-2024) & (US$ Million)
Table 117. Europe CAR T-Cell-Based Drug Market Size by Country (2024-2029) & (US$ Million)
Table 118. Asia-Pacific CAR T-Cell-Based Drug Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 119. Asia-Pacific CAR T-Cell-Based Drug Market Size by Region (2018-2024) & (US$ Million)
Table 120. Asia-Pacific CAR T-Cell-Based Drug Market Size by Region (2024-2029) & (US$ Million)
Table 121. Asia-Pacific CAR T-Cell-Based Drug Market Share by Region (2018-2024)
Table 122. Asia-Pacific CAR T-Cell-Based Drug Market Share by Region (2024-2029)
Table 123. Latin America CAR T-Cell-Based Drug Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 124. Latin America CAR T-Cell-Based Drug Market Size by Country (2018-2024) & (US$ Million)
Table 125. Latin America CAR T-Cell-Based Drug Market Size by Country (2024-2029) & (US$ Million)
Table 126. Middle East & Africa CAR T-Cell-Based Drug Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 127. Middle East & Africa CAR T-Cell-Based Drug Market Size by Country (2018-2024) & (US$ Million)
Table 128. Middle East & Africa CAR T-Cell-Based Drug Market Size by Country (2024-2029) & (US$ Million)
Table 129. CAR T-Cell-Based Drug Market Trends
Table 130. CAR T-Cell-Based Drug Market Drivers
Table 131. CAR T-Cell-Based Drug Market Challenges
Table 132. CAR T-Cell-Based Drug Market Restraints
Table 133. Research Programs/Design for This Report
Table 134. Key Data Information from Secondary Sources
Table 135. Key Data Information from Primary Sources
List of Figures
Figure 1. Global CAR T-Cell-Based Drug Market Size Year-over-Year 2018-2029 & (US$ Million)
Figure 2. Global CAR T-Cell-Based Drug Market Size (US$ Million), 2018 VS 2022 VS 2029
Figure 3. Global CAR T-Cell-Based Drug Market Share by Regions: 2022 VS 2029
Figure 4. Global CAR T-Cell-Based Drug Forecasted Market Size Share by Region (2024-2029)
Figure 5. North America CAR T-Cell-Based Drug Market Size Growth Rate (2018-2029) & (US$ Million)
Figure 6. Europe CAR T-Cell-Based Drug Market Size Growth Rate (2018-2029) & (US$ Million)
Figure 7. Asia-Pacific CAR T-Cell-Based Drug Market Size Growth Rate (2018-2029) & (US$ Million)
Figure 8. Latin America CAR T-Cell-Based Drug Market Size Growth Rate (2018-2029) & (US$ Million)
Figure 9. Middle East & Africa CAR T-Cell-Based Drug Market Size Growth Rate (2018-2029) & (US$ Million)
Figure 10. Product Picture of CD19-targeted
Figure 11. Global CD19-targeted Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 12. Product Picture of BCMA-targeted
Figure 13. Global BCMA-targeted Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 14. Global CAR T-Cell-Based Drug Market Size Share by Type: 2022 & 2029
Figure 15. North America CAR T-Cell-Based Drug Revenue Market Share by Type (2018-2029)
Figure 16. Europe CAR T-Cell-Based Drug Revenue Market Share by Type (2018-2029)
Figure 17. Asia-Pacific CAR T-Cell-Based Drug Revenue Market Share by Type (2018-2029)
Figure 18. Latin America CAR T-Cell-Based Drug Revenue Market Share by Type (2018-2029)
Figure 19. Middle East and Africa CAR T-Cell-Based Drug Revenue Market Share by Type (2018-2029)
Figure 20. Lymphoma Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 21. Multiple Myeloma Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 22. Global CAR T-Cell-Based Drug Market Size Share by Application: 2022 & 2029
Figure 23. North America CAR T-Cell-Based Drug Revenue Market Share by Application (2018-2029)
Figure 24. Europe CAR T-Cell-Based Drug Revenue Market Share by Application (2018-2029)
Figure 25. Asia-Pacific CAR T-Cell-Based Drug Revenue Market Share by Application (2018-2029)
Figure 26. Latin America CAR T-Cell-Based Drug Revenue Market Share by Application (2018-2029)
Figure 27. Middle East and Africa CAR T-Cell-Based Drug Revenue Market Share by Application (2018-2029)
Figure 28. CAR T-Cell-Based Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 29. Global Top 5 and Top 10 Players CAR T-Cell-Based Drug Market Share in 2022
Figure 30. North America CAR T-Cell-Based Drug Market Share by Country (2018-2029)
Figure 31. United States CAR T-Cell-Based Drug Market Size (2018-2029) & (US$ Million)
Figure 32. Canada CAR T-Cell-Based Drug Market Size (2018-2029) & (US$ Million)
Figure 33. Germany CAR T-Cell-Based Drug Market Size (2018-2029) & (US$ Million)
Figure 34. France CAR T-Cell-Based Drug Market Size (2018-2029) & (US$ Million)
Figure 35. U.K. CAR T-Cell-Based Drug Market Size (2018-2029) & (US$ Million)
Figure 36. Italy CAR T-Cell-Based Drug Market Size (2018-2029) & (US$ Million)
Figure 37. Russia CAR T-Cell-Based Drug Market Size (2018-2029) & (US$ Million)
Figure 38. Nordic Countries CAR T-Cell-Based Drug Market Size (2018-2029) & (US$ Million)
Figure 39. Asia-Pacific CAR T-Cell-Based Drug Market Share by Region (2018-2029)
Figure 40. China CAR T-Cell-Based Drug Market Size (2018-2029) & (US$ Million)
Figure 41. Japan CAR T-Cell-Based Drug Market Size (2018-2029) & (US$ Million)
Figure 42. South Korea CAR T-Cell-Based Drug Market Size (2018-2029) & (US$ Million)
Figure 43. Southeast Asia CAR T-Cell-Based Drug Market Size (2018-2029) & (US$ Million)
Figure 44. India CAR T-Cell-Based Drug Market Size (2018-2029) & (US$ Million)
Figure 45. Australia CAR T-Cell-Based Drug Market Size (2018-2029) & (US$ Million)
Figure 46. Latin America CAR T-Cell-Based Drug Market Share by Country (2018-2029)
Figure 47. Mexico CAR T-Cell-Based Drug Market Size (2018-2029) & (US$ Million)
Figure 48. Brazil CAR T-Cell-Based Drug Market Size (2018-2029) & (US$ Million)
Figure 49. Middle East & Africa CAR T-Cell-Based Drug Market Share by Country (2018-2029)
Figure 50. Turkey CAR T-Cell-Based Drug Market Size (2018-2029) & (US$ Million)
Figure 51. Saudi Arabia CAR T-Cell-Based Drug Market Size (2018-2029) & (US$ Million)
Figure 52. UAE CAR T-Cell-Based Drug Market Size (2018-2029) & (US$ Million)
Figure 53. Bottom-up and Top-down Approaches for This Report

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries